Cracking the Case: A Clinical Consult on Potassium Binders in Patients with Chronic Kidney Disease and Heart Failure
Pam R. Taub, MD, FACC, FASPC
Jan T. Kielstein, MD, FASN, FERA
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Ellie Kelepouris, MD, FACP, FAHA
Optimizing AAV Outcomes: Maintenance Therapies
Bernhard Hellmich, MD
Silke R. Brix, MD, MRCP, SCPR
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Andreas Kronbichler, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Elevating Care for Patients With Severe Renal Disease in AAV
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Unmasking IgAN: From Suspicion to Timely Diagnosis
Jörg Latus, MD
Chee Kay Cheung, MBCHB, MRCP, PHD
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
Mazen Hanna, MD
Cardiorenal Collaboration: Escape the Treatment Trap
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Pablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Current Experiences in Identifying and Treating Itch in Patients on Hemodialysis
James Burton, DM, FRCP
Carol Pollock, AO, MBBS, PhD, FRACP, FAHMS
Unveiling the Latest Advancements in CKD-Associated Pruritus Care
Stefan H. Jacobson, MD, PhD
Carlos Narváez Mejía, MD